Efficacy and Safety of DTG/3TC for Prophylaxis of HIV Perinatal Transmission: A Pilot Study (PREGNANCY)

Carlos Brites(Universidade Federal da Bahia), Ana Gabriela Travassos, Annemiek de Ruiter(ViiV Healthcare (Spain)), Estela Luz(Universidade Federal da Bahia), Roberto Zajdenverg(GlaxoSmithKline (Brazil)), Ivana Luz(Fundação Bahiana de Infectologia), Cynthia Lorenzo, Bryn Jones(ViiV Healthcare (United Kingdom)), Isabella Nóbrega
Open Forum Infectious Diseases
November 12, 2024
10.1093/ofid/ofae672
Cited by 2

Related Papers

Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen
|The Lancet|1996|631
Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000–2006
|AIDS|2008|582
Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000–2011
|AIDS|2014|397
Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy
|AIDS|2002|359
Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons
|New England Journal of Medicine|2024|260